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Background: Transradial (TR) access for Percutaneous Coronary Intervention (PCI) is associated with improved outcomes when compared with 
transfemoral (TF) access. We compared actual hospital costs in the US associated with TR and TF PCI.
Methods: The Premier Hospital Database, an inpatient administrative database including one-sixth of all hospitalizations in the USA, was queried 
to identify PCI pts from 2004-2009. Exclusion criteria included cardiogenic shock, multiple PCI’s during the index admission, multiple stent types 
placed and unknown myocardial infarction type. As there are no CPT codes for TR access, TR pts were identified by center level charge codes for 
radial-specific equipment or medications, and were matched 1 to many with TF pts on relevant variables. Total hospital costs were compared 
between groups. Secondary analysis was performed with pts classified as low (<1%), medium (1-3%) or high (>3%) bleeding risk. Procedural costs 
were considered all costs through the day of PCI and post-procedural costs constituted the following day through discharge.
Results: A cohort of 609 TR and 60,900 matched TF PCI patients were analyzed. Total costs for all pts were $553 lower for TR PCI (Table). Length of 
hospital stay was less in TR patients and there was no significant difference in bleeding.
Conclusions: Analysis from a national administrative database demonstrates modestly lower total costs for TR vs. TF PCI. Cost reductions are 
realized following PCI in patients with moderate or high bleeding risk.
Radial
(N=609)
Femoral
(N=60,900)
Cost Difference
(Femoral-Radial)
P-value
All Patients
Total Costs
Admit to PCI
Post PCI
11,736 (11,200-12,272)
10,655 (10,308-11,002)
1,004 (616-1,392)
12,288 (12,102-12,474)
10,672 (10,571-10,773)
1,575 (1,385-1,765)
553 (45-1,060)
17 (-318-353)
571 (229-912)
0.033
0.37
0.001
Low Bleeding Risk
Total Costs
Admit to PCI
Post PCI
11,841 (10,791-12,891)
11,280 (10,409-12,150)
592 (29-1,156)
11,417 (11,167-11,667)
10,601 (10,311-10,891)
814 (680-948)
-424 (-1,454-605)
-679 (-1,507-150)
222 (-331-775)
0.419
0.108
0.431
Mod Bleeding Risk
Total Costs
Admit to PCI
Post PCI
11,294 (10,638-11,950)
10,516 (10,060-10,971)
659 (209-1,108)
11,879 (11,691-12,067)
10,668 (10,530-10,806)
1,136 (941-1,331)
585 (-49-1,219)
152 (-285-590)
478 (69-887)
0.071
0.495
0.022
High Bleeding Risk
Total Costs
Admit to PCI
Post PCI
12,844 (11,545-14,143)
10,550 (9,863-11,237)
2,276 (1,245-3,307)
13,890 (13,359-14,421)
10,692 (10,517-10,868)
3,193 (2,671-3,714)
1,046 (-150-2,242)
142 (-528-812)
917 (19-1,814)
0.086
0.677
0.045
Length of Stay
Total
Admit to PCI
Post PCI
2.15 (1.9-2.4)
1.7 (1.58-1.82)
0.47 (0.27-0.66)
2.42 (2.28-2.56)
1.65 (1.61-1.69)
0.78 (0.67-0.89)
N/A
0.014
0.37
<0.001
